Nasdaq

Medtronic Announces FDA Approval for MiniMed™ 770G Insulin Pump System with Smartphone Connectivity for People with Type 1 Diabetes

DUBLIN, Sept. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its ...
Drug Delivery Business

Medtronic begins rollout of MiniMed 780G with Instinct sensor made by Abbott

Medtronic (NYSE:MDT) announced that its Instinct sensor, made by Abbott, is now available to order with the MiniMed 780G pump ...
Seeking Alpha

New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes

With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn ...
MobiHealthNews

Medtronic's MiniMed 770G scores FDA clearance for kids, adults

Medtronic’s MiniMed 770G System has landed FDA clearance for its hybrid closed-loop system, marking the first time an automated insulin delivery system was greenlighted for young children with Type 1 ...